transcatheter


Also found in: Dictionary.

transcatheter

 [trans-kath´ĕ-ter]
performed through the lumen of a catheter.

transcatheter

/trans·cath·e·ter/ (trans-kath´ĕ-ter) performed through the lumen of a catheter.

transcatheter

performed through the lumen of a catheter. Includes the delivery of intravascular devices such as balloon, coils and stents to dilate or close cardiovascular defects. See also balloon valvuloplasty.
References in periodicals archive ?
Although mitral valvular disease has a higher prevalence, transcatheter valve replacement was applied in aortic valvular more extensively due to the relatively simple anatomic feature.
Medical company BioVentrix Inc reported on Friday that it has enrolled the first patient under the international arm of the ALIVE pivotal clinical trial to demonstrate the safety and effectiveness of the Revivent TC TransCatheter Ventricular Enhancement System for treating patients suffering from ischemic cardiomyopathy.
Results: There were one hundred and twenty (120) patients who underwent transcatheter occlusion of PDA using SHSMA occluder (PDA Device Group) and one hundred and thirty (130) patients who underwent surgical ligation of PDA (Surgical Group).
Transcatheter heart valves: Transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve replacement (TMVR) devices
Transcatheter heart valve replacement is a relatively non-invasive procedure to repair the damaged heart valves with bioprosthetic valves for treatment of valvular heart disease namely aortic stenosis and mitral regurgitation among geriatric population.
The tricuspid valve appears to be lined up to become the next major spot of R&D interest in transcatheter cardiac valve tech.
Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial.
Transcatheter Technologies has developed a range of transcatheter valve implantation systems for catheter-based heart valve therapy.
Transcatheter closure of perimembranous ventricular septal defect in children: safety and efficient with symmetric and asymmetric occluders.
Edwards Lifesciences has bolstered its transcatheter therapy portfolio by acquiring CardiAQ Valve Technologies for $400 million.
Objectives: To determine in paediatric patients with atrial septal defects whether differences in P wave dispersion occurred with transcatheter closures using the Amplatzer septal occluder.
The transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation (TAVI) operations are the first ever in Bahrain.

Full browser ?